Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Chemoprevention, Aspirin and CRC

Andrew Chan

MD, MPH

🏢Massachusetts General Hospital / Harvard Medical School🌐USA

Vice Chair of Gastroenterology, Chief of Clinical and Translational Epidemiology Unit

120
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Andrew Chan is the leading investigator of aspirin chemoprevention of colorectal cancer, drawing on the Nurses Health Study, Health Professionals Follow-up Study, and randomized trials. He also investigates gut microbiome effects on cancer. He chairs clinical and translational epidemiology at MGH.

Share:

🧪Research Fields 研究领域

aspirin chemoprevention
colorectal cancer prevention
NHS/HPFS
Nurses Health Study
gut microbiome

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Andrew Chan 的研究动态

Follow Andrew Chan's research updates

留下邮箱,当我们发布与 Andrew Chan(Massachusetts General Hospital / Harvard Medical School)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment